跳至主要内容
临床试验/NL-OMON47850
NL-OMON47850尚未招募不适用

The evaluation of the cerebellar symptoms in patients with opsoclonus myoclonus syndrome diagnosed and treated at the Sophia*s Children*s hospital - Evaluation of long term sequelae and treatment outcomes in OMS

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 11(—)

入选标准

  • All patients with OMS, diagnosed and treated at the Sophia Children*s Hospital will be included. OMS is defined as the presence of *3 of the following symptoms: [1] opsoclonus, [2] myoclonus and/or ataxia, [3] behavioural change and/or sleep disturbance and [4] neuroblastoma.
  • Age-matched children with pilocytic astrocytoma, diagnosed and treated at the Sophia Children*s Hospital will be included.

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • - Insufficient command of the Dutch language (spoken and/or written)
  • - Age above 12 years
  • Children with pilocytic astrocytoma will be excluded from participation, when they were treated with radiotherapy.

研究者

相似试验